chrisvoncsefalvay/vaers-outcomes huggingface dataset:
all the patients who received a vaccine which was more than 30 days in the refrigerator; all the patients who received a vaccine which was more than 30 days in the refrigerator; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (all the patients who received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (all the patients who received a vaccine which was more than 30 days in the refrigerator) in a 31-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (all the patients who received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (all the patients who received a vaccine which was more than 30 days in the refrigerator). On 29-Jul-2021, EXPIRED PRODUCT ADMINISTERED (all the patients who received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (all the patients who received a vaccine which was more than 30 days in the refrigerator) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of EXPIRED PRODUCT ADMINISTERED, and PRODUCT STORAGE ERROR, in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination with no associated Adverse events.
Breakthrough case. Was near someone with COVID. I received my 4th dose of Moderna in 04/2022, then on 07/01/2022 I tested positive for COVID at both the home and the clinic. Before COVID testing I had severe congestion. The urgent care prescribed me LIDOCAINE VISCOUS, FLONASE. Decided not to take any. Doing ok now, tested and negative for COVID.
Patient faint and displayed seizure like symptoms (tremor, body tightening, sweating, staring gaze) for 3-4 seconds after receiving vaccinations. Reaction occurred within seconds of last vaccine. Patient refused emergency care. Patient returned to alert status under 1/2 minute. After sitting for 1/2 hr patient left
Diarrhea/loose stools -- every day since day AFTER vaccine was received (6 days, so far)
Red, horribly itchy bumps all over body; Red, horribly itchy bumps all over body; Red, horribly itchy bumps all over body; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Aug2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included few unspecified histories and known allergies to penicillin, shellfish and hares. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications (reported as the patient had received same medications for over a year). On 30Aug2021, the patient experienced red, horribly itchy bumps all over the body which was not really like hives, but more like chickenpox or shingles. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with steroids, creams and lotions. Since the vaccination, the patient had been tested for COVID-19. On 01Sep2021, the patient underwent Nasal Swab CoV-2 test and the result was negative. The clinical outcome of the events red, horribly itchy bumps all over body was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Post vaccine pt complained of chest pain. Denied other symptoms. Pt noted symptoms worsened with sitting/leaning and improved while standing. EMS evaluation revealed sinus tachycardia, HR 140, BP 164/94. Repeat vitals normal sinus rhythm. Symptoms resolved and pt went home.
RN Message Notes: KEY SYMPTOMS:immunization, headache, joint pain, knees, arms, neck (s/p fever 100, chills last night). ONSET/DURATION/INTENSITY:last night, better today, pain 3/10 PERTINENT HISTORY:recieved SHINGRIX 1/22. TRIED (BETTER/WORSE):antihistamine, shower, helps plans to take ALEVE. Additional Information: See RN call notes.
Moderna COVID?19 Vaccine EUA Pain, induration, pruritis at injection site. Elliptical-shaped, raised plaque, blanching; warm and tender to palpation
Expired Bexsero administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number ABXC06AA, expiry date 31-MAR-2023) for prophylaxis.   On 05-APR-2023, the patient received Bexsero. On 05-APR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Expired Bexsero administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Receipt Date: 24-APR-2023 The reporter consented to follow up by email. The patient received a dose of Bexsero which was expired on March 31, 2023, which led to expired vaccine used
60-year-old male with complaint of palpitations and shortness of breath since 3 days ago after getting his 1st Moderna COVID vaccine.  He states that the palpitations started right when they put the needle in his arm.  He states that he does have some history of anxiety and depression but that this feels different.
Pain in arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and PAIN IN EXTREMITY (Pain in arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR ORIFARM) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced FATIGUE (fatigue). On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 20-Jan-2021, FATIGUE (fatigue) had resolved. On 26-Jan-2021, PAIN IN EXTREMITY (Pain in arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
She got a red rash on both arms the first night after the shot. Then in the following days she developed what seemed like a cold, then a day or two later developed a fever and also vomiting. She continued to be sick and was put on antibiotics that did not help. We took her to see a specialist who said her adenoids were swollen. She would then be seen and finally treated with steroids. It took her over 5 months to recover. Until she got her next shot of the same type and then the same symptoms occurred again.
Moderna vaccine expired on 22-JAN-2022 and administered on 24-JAN-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine expired on 22-JAN-2022 and administered on 24-JAN-2022) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2022 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine expired on 22-JAN-2022 and administered on 24-JAN-2022). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine expired on 22-JAN-2022 and administered on 24-JAN-2022) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter. It as given as a booster dose.
Bradycardia as low as 36 bpm, very erratic heart rate for ~5 days; went to local ER, was triaged and then transferred to a medical center for overnight observation and testing. Bradycardia and erratic heart rate confirmed by cardiologist and all tests. Both cardiologist and family physician felt all heart issues were likely due to the Covid booster I had last received. All issues resolved after ~10 days.
clear fluid leaked from the injection site; Possible the dose was given subcutaneously; This case was reported by a pharmacist via call center representative and described the occurrence of injection site leaking in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 43GJ4, expiry date 1st December 2021) for prophylaxis.   On 20th May 2020, the patient received the 2nd dose of Shingrix. On 20th May 2020, 3 min after receiving Shingrix, the patient experienced injection site leaking and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site leaking and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the injection site leaking to be related to Shingrix.  Additional details were provided as follows: It was reported that the patient received the second dose for Shingrix and 3 minutes after the vaccine was administer, a clear fluid leaked from the injection site. The pharmacist stated that the injection was administered through an onion-skin adhesive bandage according to the pharmacy procedures.  The patient had a large amount of adipose tissue, and it was possible the dose was given subcutaneously instead of intramuscular into the deltoid which led to intramuscular formulation administered by other route.  The pharmacist was unsure how much volume leaked from the site, but he did believe the liquid that leaked was the vaccine. It was reported that the patient did not experienced any adverse events. The reporter consented to follow up.
Extreme tiredness. Headache. Nausea. Pain at injection site and further down arm. Weakness.
Labored breathing/shortness of breath; Extreme fatigue; Resting heart rate 104 bpm; Full body myalgias; Nausea; This is a spontaneous report from a contactable pharmacist. A 28-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), intramuscular at the left arm on 09Jan2021 17:00 at a single dose for COVID-19 immunization at a clinic. Medical history was reported as none. Patient has no known allergies. The patient was not pregnant. Concomitant medication included desogestrel, ethinylestradiol (VELIVET). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular at the left arm  on 21Dec2020 14:45. The patient experienced full body myalgias, nausea, extreme fatigue, resting heart rate 104 bpm, and labored breathing/shortness of breath on 10Jan2021, 04:30. There was treatment for the adverse events. Patient has not been tested for COVID 19 prior and post vaccination. The patient was recovering from the events.
On 2/8 woke up to a hard knot at the injection site (upper left arm/shoulder). It was red and hot and painful. Iced the injection site and took acetaminophen.  On 2/9 woke up with a fever of 100.6 and felt dizzy. Took acetaminophen and drank fluids. Continuing to run low grade fever from 99.5-100 degrees.  The redness has spread across the shoulder by more than double but not quite as raised - as if it's dispersing.
Leg and arm pain, nausea and twitching of abdominal muscles, numbness in left side of head neck and torso, hot flashes up and down body, fatigue, headache, ringing in left ear, overall body sick feeling, sharp quick pains in legs and arms and joints.
pt recv vax 13NOV96 & pt began breaking out in large whelps on the face;whelps started to disappear around 5PM;pt still breaking out w/whelps on face;pt taken to ER;
loss of hearing in left ear, under going treatment with steroid injections once week 3 times at present, with MRI w/wo contrast, blood tests. Treatment still in progress as of 02/ 18/2021
I received the shot Tuesday afternoon. Friday evening of the same week at around 7pm I was standing outside and started feeling cold on a night that wasn't terribly cold.  I started shivering uncontrollably. I jumped into bed and got under the covers in an attempt to re-warm myself.  I cold not stop shivering and eventually fell asleep. Approximately 30 minutes later I woke up and started dry heaving in the toilet. When I finished dry heaving I came out of the bathroom soaked from head to toe in sweat.  I've never had anything like this happen to me.
Pt recvd 2nd dose of vax & pt c/o soreness @ inject site; no further details were provided;
Vaccine expired on 01-Apr-2022, initially stored in the refrigerator on 04-Apr-2022 and then administered on 11-Apr-2022; Expired vaccine administered to 155 patients/80 patients received expired Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/80 patients received expired Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, initially stored in the refrigerator on 04-Apr-2022 and then administered on 11-Apr-2022) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/80 patients received expired Moderna COVID-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, initially stored in the refrigerator on 04-Apr-2022 and then administered on 11-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/80 patients received expired Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, initially stored in the refrigerator on 04-Apr-2022 and then administered on 11-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   The vial was initially stored in the refrigerator on 04-Apr-2022.   The vial had not undergone any temperature excursion.   The pharmacist reported that the pharmacist thought that the vaccine would expire in Jun-2022 however the vaccine expired on 01-Apr-2022.   No treatment information was reported.
I first noticed symptoms on 03/08/2023 I had a runny nose, felt achy and had a non productive dry cough. I took a home COVID-19 test and was positive. I contacted my Physician and I was advised not to take Paxlovid as it may cause a drug interaction with Brilinta. I treated it with OTC Decongestant and Antihistamine.
Lump at injection site, itching in the evening of vaccine recieved.  This morning 11:30am. Left arm numbness, tightness lump at injection site still, no fever, headache, tired at 1:15pm
Injection site pain, left arm from shoulder to elbow, severe enough to make moving the arm difficult; started post-injection and escalated, peaking about a day post-injection  and resolving after three days post-injection Mild fatigue, began about four hours post-injection and resolved about a day and a half post-injection Vaginal discharge, noticed the day after injection; may still have been ongoing two days after injection but difficult to say due to menstrual period starting two days post-injection Tylenol was taken in accordance with package labelling two days post-injection to mitigate menstrual cramps, which also helped the injection site pain
I received vaccine dose #1, 12/30/20 3:40pm. I broke out in hives covering most of my body 2 1/2 days after the vaccine, 1/2/2021 7:15am, and became short of breath.  I was treated at the emergency department with iv benadryl and solu-medrol.   I premedicated with zyrtec and benadryl prior to the second dose 1/20/2021 3:40pm  and had a breakout of hives around my hairline and upper back around 1:30 am the following early morning after administration, 1/21/2021.   I took benadryl around the clock every 4-6 hours the next day.  I took an am dose the following day.  1/24/2021 9am, I had hives appear in several patches on different body parts which were controlled with benadryl and hydrocortisone cream.
I'm not sure that it's connected to the vaccine at all, but I developed left hip pain in December 2022 or January 2023. I don't know what caused it, and neither does my chiropractor. My doctor has suggested stretches and exercises to me, but they aren't helping much. The thing that helps the most is a massage. I have not seen my PCP about my hip pain, though.
had her first Shingrix shot / diagnosed with AFib about six weeks ago; This case was reported by a consumer via call center representative and described the occurrence of atrial fibrillation in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID-19 VACCINE UNKNOWN) for prophylaxis.   The patient's past medical history included shingles (full blown case of shingles in September 2020 but on the left side), pain (in September 2020 had pain after four days of shingles on lower left side that lasted for 3 months) and rash (on the lower left side in September 2020). Concomitant products included COVID-19 VACCINE (COVID-19 VACCINE UNKNOWN).   In January 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of COVID-19 VACCINE UNKNOWN. In April 2021, less than 4 months after receiving Shingrix, the patient experienced atrial fibrillation. The patient was treated with apixaban (Eliquis). On an unknown date, the outcome of the atrial fibrillation was unknown.   It was unknown if the reporter considered the atrial fibrillation to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The patient had her first Shingrix shot at the end of January 2021 and she had no problems after the first shot. The patient stated that she received 2 doses of the COVID Vaccine (did not specify which one) sometime after receiving the 1st dose of Shingrix. The patient mentioned she was diagnosed with atrial fibrillation about six weeks ago from the time of reporting. The patient was prescribed Eliquis to treat the atrial fibrillation and the patient took her first dose of Eliquis about three weeks ago from the time of reporting. It was unknown if the reporter considered the atrial fibrillation to be related to COVID Vaccine. For tolerance after 2nd dose, refer case US2021AMR125805.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR125805:same reporter, same patient - (2nd dose)
White patches, slight lingual swelling; swollen lymph nodes - neck; low grade fever - 100;
Vaccine expiration 06/31/2022 from manufactory date of October 2021. Patient given injection 1 day post expiration date. Patient reports no problems when contacted.
On second day: flu symptoms t 100.2. Reaction redness rash inflammation on (L) arm.
Hives on chest, left arm, and right arm.  So far continuing for 2 days.  Not itchy, just red and bumpy.
Brain Fog; scheduled to receive a second dose 3 weeks later but he did not show up; Fever; Long Hauler COVID- Disease Symptoms; flu symptoms; Pains; diarrhea; nausea; Soreness; Severe Aches; COVID disease; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu symptoms), PAIN (Pains), FEELING ABNORMAL (Brain Fog), PRODUCT ADMINISTRATION INTERRUPTED (scheduled to receive a second dose 3 weeks later but he did not show up) and COVID-19 (COVID disease) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (Pains), DIARRHOEA (diarrhea), NAUSEA (nausea), VACCINATION SITE PAIN (Soreness) and MYALGIA (Severe Aches). On 17-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA (flu symptoms). In 2021, the patient experienced COVID-19 (COVID disease). In April 2022, the patient experienced POST-ACUTE COVID-19 SYNDROME (Long Hauler COVID- Disease Symptoms). On an unknown date, the patient experienced FEELING ABNORMAL (Brain Fog), PRODUCT ADMINISTRATION INTERRUPTED (scheduled to receive a second dose 3 weeks later but he did not show up) and PYREXIA (Fever). At the time of the report, INFLUENZA (flu symptoms), PAIN (Pains), DIARRHOEA (diarrhea), NAUSEA (nausea), VACCINATION SITE PAIN (Soreness), MYALGIA (Severe Aches) and PYREXIA (Fever) had not resolved and FEELING ABNORMAL (Brain Fog), PRODUCT ADMINISTRATION INTERRUPTED (scheduled to receive a second dose 3 weeks later but he did not show up), COVID-19 (COVID disease) and POST-ACUTE COVID-19 SYNDROME (Long Hauler COVID- Disease Symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: Positive. On an unknown date, Body temperature: 100F. On an unknown date, Pathology test: he was fine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided. After first vaccination patient had a reaction Soreness, Flu Symptoms, Diarrhea, Nausea, and Severe Aches and Pains. Patient went to the emergency room. All symptoms went away 2 days after vaccination.Late in 2021, after Holidays, patient had COVID disease and tested positive for Omicron. COVID Disease symptoms had Flu like symptoms, Aches and Pain, and a Fever 100F for 2 weeks.  Patient was fine and in APR2022 Patient got the same symptoms as when he had COVID Disease. Patient called it a Long Hauler COVID- Disease Symptoms. Patient has Brain Fog, Aches & Pains on and off since he had COVID disease. No treatment medications was provided.   Reporter did not allow further contact